Capivasertib is an AKT inhibitor specifically for HR /HER2breast cancer patients with alterations in PIK3CA/AKT1/PTEN. It works by stopping the AKT signal from doing its thing. You’ve got the 200 mg and the 400 mg tablet options here.
The usual dose is 400 mg, two times a day. You take it for four days, then take a 3-day break. Each bottle has 64 tablets.
